FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103151974> ?p ?o ?g. }

• W2103151974 endingPage "326" @default.
• W2103151974 startingPage "320" @default.
• W2103151974 abstract "The paclitaxel, fluorouracil, and hydroxyurea regimen of paclitaxel, infusional fluorouracil, hydroxyurea, and twice-daily radiation therapy (TFHX) administered every other week has resulted in 3-year survival rates of 60% of stage IV patients. Locoregional and distant failure rates were 13% and 23%, respectively. To reduce distant failure rates, we added a brief course of induction chemotherapy to TFHX.Sixty-nine patients received six weekly doses of carboplatin (AUC2) and paclitaxel (135 mg/m2) followed by five cycles of TFHX.Ninety-six percent had stage IV disease. Response to induction chemotherapy was partial response 52% and complete response (CR) 35%. Symptomatically, there was a significant reduction in mouth and throat pain. The most common grade 3 or 4 toxicity was neutropenia (36%). Best response following completion of TFHX was CR in 83%. Toxicities of TFHX consisted of grade 3 or 4 mucositis (74% and 2%) and dermatitis (47% and 14%). At a median follow-up of 28 months, locoregional or systemic disease progression were each noted in five patients. The overall 3-year progression-free survival was 80% (95% confidence interval [CI], 71% to 90%), and the 2- and 3-year overall survival rates were 77% (95% CI, 66% to 87%) and 70% (95% CI, 59% to 82%), respectively. At 12 months, five patients were completely feeding-tube dependent.Administration of carboplatin and paclitaxel before TFHX chemoradiotherapy results in high response activity and may decrease distant failure rates. Overall survival, progression, and organ preservation/functional outcome data support definitive evaluation of this approach." @default.
• W2103151974 created "2016-06-24" @default.
• W2103151974 creator A5000384489 @default.
• W2103151974 creator A5005605876 @default.
• W2103151974 creator A5017187936 @default.
• W2103151974 creator A5038481817 @default.
• W2103151974 creator A5051856622 @default.
• W2103151974 creator A5054855052 @default.
• W2103151974 creator A5056297454 @default.
• W2103151974 creator A5059298173 @default.
• W2103151974 creator A5063904421 @default.
• W2103151974 creator A5073342619 @default.
• W2103151974 creator A5077414631 @default.
• W2103151974 creator A5077701955 @default.
• W2103151974 creator A5083210990 @default.
• W2103151974 creator A5084675974 @default.
• W2103151974 date "2003-01-15" @default.
• W2103151974 modified "2023-10-11" @default.
• W2103151974 title "Weekly Carboplatin and Paclitaxel Followed by Concomitant Paclitaxel, Fluorouracil, and Hydroxyurea Chemoradiotherapy: Curative and Organ-Preserving Therapy for Advanced Head and Neck Cancer" @default.
• W2103151974 cites W1784479792 @default.
• W2103151974 cites W1858398661 @default.
• W2103151974 cites W1924502059 @default.
• W2103151974 cites W1925051373 @default.
• W2103151974 cites W1936206127 @default.
• W2103151974 cites W1953373541 @default.
• W2103151974 cites W1970127566 @default.
• W2103151974 cites W1995294678 @default.
• W2103151974 cites W2000355459 @default.
• W2103151974 cites W2015167754 @default.
• W2103151974 cites W2022395184 @default.
• W2103151974 cites W2022856366 @default.
• W2103151974 cites W2029409133 @default.
• W2103151974 cites W2064810566 @default.
• W2103151974 cites W2072586204 @default.
• W2103151974 cites W2086437149 @default.
• W2103151974 cites W2097584581 @default.
• W2103151974 cites W2105258029 @default.
• W2103151974 cites W2112275574 @default.
• W2103151974 cites W2112778345 @default.
• W2103151974 cites W2123605459 @default.
• W2103151974 cites W2139473442 @default.
• W2103151974 cites W2139554459 @default.
• W2103151974 cites W2144208072 @default.
• W2103151974 cites W2146148650 @default.
• W2103151974 cites W2151415400 @default.
• W2103151974 cites W2151616125 @default.
• W2103151974 cites W2152609192 @default.
• W2103151974 cites W2152630182 @default.
• W2103151974 cites W2157885764 @default.
• W2103151974 cites W2172288146 @default.
• W2103151974 cites W2226021524 @default.
• W2103151974 cites W2258719021 @default.
• W2103151974 cites W2272017712 @default.
• W2103151974 cites W2331395194 @default.
• W2103151974 cites W2562414697 @default.
• W2103151974 cites W4240814623 @default.
• W2103151974 cites W4256175619 @default.
• W2103151974 doi "https://doi.org/10.1200/jco.2003.06.006" @default.
• W2103151974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12525525" @default.
• W2103151974 hasPublicationYear "2003" @default.
• W2103151974 type Work @default.
• W2103151974 sameAs 2103151974 @default.
• W2103151974 citedByCount "222" @default.
• W2103151974 countsByYear W21031519742012 @default.
• W2103151974 countsByYear W21031519742013 @default.
• W2103151974 countsByYear W21031519742014 @default.
• W2103151974 countsByYear W21031519742015 @default.
• W2103151974 countsByYear W21031519742016 @default.
• W2103151974 countsByYear W21031519742017 @default.
• W2103151974 countsByYear W21031519742018 @default.
• W2103151974 countsByYear W21031519742019 @default.
• W2103151974 countsByYear W21031519742020 @default.
• W2103151974 countsByYear W21031519742021 @default.
• W2103151974 countsByYear W21031519742022 @default.
• W2103151974 countsByYear W21031519742023 @default.
• W2103151974 crossrefType "journal-article" @default.
• W2103151974 hasAuthorship W2103151974A5000384489 @default.
• W2103151974 hasAuthorship W2103151974A5005605876 @default.
• W2103151974 hasAuthorship W2103151974A5017187936 @default.
• W2103151974 hasAuthorship W2103151974A5038481817 @default.
• W2103151974 hasAuthorship W2103151974A5051856622 @default.
• W2103151974 hasAuthorship W2103151974A5054855052 @default.
• W2103151974 hasAuthorship W2103151974A5056297454 @default.
• W2103151974 hasAuthorship W2103151974A5059298173 @default.
• W2103151974 hasAuthorship W2103151974A5063904421 @default.
• W2103151974 hasAuthorship W2103151974A5073342619 @default.
• W2103151974 hasAuthorship W2103151974A5077414631 @default.
• W2103151974 hasAuthorship W2103151974A5077701955 @default.
• W2103151974 hasAuthorship W2103151974A5083210990 @default.
• W2103151974 hasAuthorship W2103151974A5084675974 @default.
• W2103151974 hasConcept C126322002 @default.
• W2103151974 hasConcept C141071460 @default.
• W2103151974 hasConcept C2776611710 @default.
• W2103151974 hasConcept C2776694085 @default.
• W2103151974 hasConcept C2777063308 @default.
• W2103151974 hasConcept C2777292972 @default.
• W2103151974 hasConcept C2778239845 @default.
• W2103151974 hasConcept C2778424827 @default.

• next